Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
Resmed (NYSE: RMD) will report second quarter fiscal 2026 financial and operational results on Thursday, January 29, 2026 after NYSE close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Resmed (NYSE: RMD) will report second quarter fiscal 2026 financial and operational results on Thursday, January 29, 2026 after NYSE close. Management will host a live webcast discussing results and other forward-looking material at 1:30 p.m. PST / 4:30 p.m. EST (International: London 9:30 p.m. GMT; Sydney Jan 30 8:30 a.m. AEDT).
The webcast is available only at https://investor.resmed.com. A replay will be posted ~two hours after the webcast; a phone replay is available ~three hours after the webcast through February 12, 2026 (Conference ID: 13757750).
Details
News Market Reaction – RMD
On Jan 9, the first trading day after this news, RMD closed 0.62% above the previous close.
Data tracked by StockTitan Argus for the Jan 9 session.
Key Figures
- Earnings release date
- January 29, 2026
- Q2 fiscal 2026 results to be released after NYSE close
- Webcast time (US)
- 1:30 p.m. PST / 4:30 p.m. EST
- Management webcast to discuss Q2 FY26 results
- Webcast link
- https://investor.resmed.com
- Access point for Q2 FY26 earnings webcast and replay
- Replay availability
- Jan 29–Feb 12, 2026
- Phone replay window following the Q2 FY26 webcast
- Replay delay (webcast)
- Approximately 2 hours
- Time after webcast when online replay becomes accessible
- Replay delay (phone)
- Approximately 3 hours
- Time after webcast when phone replay becomes accessible
- Conference ID
- 13757750
- Identifier required for phone replay access
Historical Context
-
Announcement of presentation at J.P. Morgan Healthcare Conference with webcast access.
-
FDA clearance for AI-enabled Smart Comfort CPAP comfort settings product launch.
-
Reported Q1 FY26 revenue growth, margin expansion, strong EPS and cash flow.
-
Announcement of timing and webcast details for Q1 FY26 earnings release.
-
Participation announcement for Bank of America Global Healthcare Conference with webcast.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
| Earnings webcast details: | ||
| • | Location: | https://investor.resmed.com |
| • | Date: | Thursday, January 29, 2026 |
| • | Time: | 1:30 p.m. PST / 4:30 p.m. EST |
| • | International: | London, Thursday, January 29, 2026, 9:30 p.m. GMT |
| Sydney, Friday, January 30, 2026, 8:30 a.m. AEDT | ||
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from January 29, 2026, until February 12, 2026, at:
- U.S.: +1 877.660.6853
- International: +1 201.612.7415
- Conference ID: 13757750
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For investors | For media |
| +1 858.221.3304 | +1 619.510.1281 |
| investorrelations@Resmed.com | news@Resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.